Navigation Links
Food Colour in Sausages, Burgers Could Trigger Cancer

Food specialists have warned that a dye, used sometimes to colour meat for sausages and burgers, could trigger cancer .

The European Food Safety Authority (EFSA) recently announced that it could no longer guarantee a safe daily limit for consumers to eat meat with the colourant, Red 2G, which is also known as E128.

EFSA released a statement describing Red 2G, as a "safety concern". A meeting has been called by the Food Standards Agency on July 10, to establish the extent of the use of the dye in Britain.

Many large brands have recently been trying to do away with additives and artificial colourings from their meat products. However, E128 is still frequently used, particularly in economy sausages and burgers.

Under current EU food laws, limited amounts of Red 2G are permitted for use only in certain types of breakfast sausages and burger meat.

The EFSA experts said Red 2G was converted in the body into a substance called aniline. Following tests on rats and mice, the researchers concluded that aniline should be considered as a carcinogen or cancer-causing.

"Based on similar metabolism of aniline in animals and humans, a carcinogenic risk for man cannot therefore be excluded," the Telegraph quoted a spokesman for the EFSA, as saying.

"Given new scientific evidence it cannot be excluded that aniline's carcinogenic potential is due to damage to the genetic material of the cells. It is therefore not possible to determine a level of intake for aniline which may be regarded as safe for humans," he added.

A spokesman for the FSA said that once the meeting is concluded, the agency will decide what action to take.

The EFSA is re-assessing the scientific evidence on all food colourings as part of a wider review of a range of food additives presently authorised for use in the EU.

A spokesman for the Food and Drink Federation, which represe nts UK manufacturers, said the use of E128 here was "likely to be minimal".


'"/>




Related medicine news :

1. Colour Identification Lies Wholly On the Left Hemisphere of the Brain.
2. Colour Of Urine Can Reveal The Health Status Of The Patients
3. Colourful vegetables lower asthma risk
4. Type 2 Diabetes Could Be Tackled Using Curry Colouring and Fat Mix
5. Red 2G Food Colour to Be Banned by EU Due to Cancer Fears
6. Researchers Reveal Why Eyes See Things Changing Colour
7. Lean Protein Could Be Key to Obesity Drugs
8. Nasal Spray Could Take Drugs Direct to Brain.
9. Nasal Spray Could Take Drugs Directly to Brain
10. Oxygen Usage During Exercise Could Indicate Heart Problems
11. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: